ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: George Santos Wins Bristol-Meyers Award; SG Elects William Creasman President; Levin To MDA

April 1, 1988

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991

Translucent Walls, Modern Classics Create “Corporate Feel” In Office Suite Occupied By Wife of MD Anderson President DePinho

May 24, 2013

DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies

May 19, 1989

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009